CIK 0001372299
- Non-accelerated filer
- Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Executive Officer bought 406,000 shares at an average $0.39 ($157,880)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 220,000 shares at $0.44 ($96,800)
- 4/A Open-market buy Director bought 98,500 shares at $0.41 ($40,385)
- 4 Open-market buy Director bought 270,000 shares at $0.37 ($99,900)
- 4 Open-market buy Director bought 195,000 shares at an average $0.27 ($53,450)
Page 9 of 15 · 288 filings